Rheumatic Fever (Streptococcus pyogenes - Group A Streptococcus)
Overview
Plain-Language Overview
Rheumatic Fever is an inflammatory disease that can develop after an infection with the bacteria Streptococcus pyogenes, also known as Group A Streptococcus. It mainly affects the heart, joints, skin, and brain. The condition occurs when the body's immune system mistakenly attacks its own tissues, especially the heart valves, following a throat infection. This can lead to symptoms like joint pain, fever, and sometimes heart problems. If untreated, it can cause long-term damage to the heart, known as rheumatic heart disease. The disease primarily affects children and young adults. Early recognition and treatment of the initial infection are important to prevent this complication.
Clinical Definition
Rheumatic Fever is a systemic inflammatory disorder triggered by an autoimmune response to infection with Streptococcus pyogenes (Group A Streptococcus). It typically follows untreated or inadequately treated streptococcal pharyngitis by 2 to 4 weeks. The core pathology involves molecular mimicry, where antibodies against streptococcal antigens cross-react with host tissues, particularly in the heart, joints, skin, and central nervous system. The major clinical significance lies in its potential to cause acute carditis and chronic rheumatic heart disease due to valvular damage. Other manifestations include migratory polyarthritis, Sydenham chorea, erythema marginatum, and subcutaneous nodules. Diagnosis relies on clinical criteria supported by evidence of recent streptococcal infection.
Inciting Event
Pharyngeal infection with Streptococcus pyogenes (Group A Streptococcus) initiates the disease.
Untreated or partially treated streptococcal pharyngitis triggers the autoimmune response.
Exposure to rheumatogenic strains of S. pyogenes with specific M protein serotypes is critical.
Latency Period
Symptoms typically develop 2-4 weeks after the initial streptococcal pharyngitis.
Latency allows for development of adaptive immune response and cross-reactive antibodies.
Delayed onset complicates direct linkage to preceding infection in clinical history.
Diagnostic Delay
Nonspecific early symptoms such as fever and malaise lead to misattribution to viral illness.
Lack of recent documented streptococcal infection may obscure clinical suspicion.
Overlap with other causes of arthritis or carditis delays recognition of rheumatic fever.
Variable presentation and absence of pathognomonic tests complicate early diagnosis.
Clinical Presentation
Signs & Symptoms
Fever and malaise following untreated or inadequately treated pharyngitis
Migratory polyarthritis affecting large joints such as knees and ankles
Carditis presenting with chest pain, tachycardia, or heart failure symptoms
Erythema marginatum rash appearing on trunk and proximal limbs
Sydenham chorea manifesting as involuntary, purposeless movements
History of Present Illness
Initial presentation often includes migratory polyarthritis affecting large joints.
Fever, fatigue, and malaise precede or accompany joint symptoms.
Carditis manifests as chest pain, dyspnea, or palpitations in some patients.
Erythema marginatum and subcutaneous nodules may appear later in the course.
Sydenham chorea presents as involuntary movements weeks after initial symptoms.
Past Medical History
Recent history of untreated or inadequately treated streptococcal pharyngitis is common.
Previous episodes of rheumatic fever increase risk of recurrent disease and chronic valvular damage.
History of frequent sore throats or streptococcal infections may be present.
Lack of prior antibiotic prophylaxis in patients with known rheumatic heart disease worsens prognosis.
Family History
Family history of rheumatic fever or rheumatic heart disease suggests genetic susceptibility.
Certain HLA class II alleles associated with increased risk may cluster in families.
No clear Mendelian inheritance pattern but familial clustering is recognized.
Physical Exam Findings
Carditis with a new or changed heart murmur, often a mitral regurgitation murmur
Subcutaneous nodules over extensor surfaces such as elbows and knees
Erythema marginatum, a nonpruritic, serpiginous rash with central clearing
Sydenham chorea, characterized by rapid, involuntary movements and hypotonia
Arthritis with swollen, tender, and warm large joints, typically migratory
Diagnostic Workup
Diagnostic Criteria
Diagnosis of rheumatic fever is established using the Jones criteria, which require evidence of recent Group A Streptococcus infection plus the presence of either two major criteria or one major and two minor criteria. Major criteria include carditis, polyarthritis, Sydenham chorea, erythema marginatum, and subcutaneous nodules. Minor criteria include fever, arthralgia, elevated acute phase reactants (ESR or CRP), and prolonged PR interval on ECG. Confirmation of recent streptococcal infection is typically done by positive throat culture, rapid antigen test, or elevated anti-streptolysin O (ASO) titers.
Pathophysiology
Key Mechanisms
Molecular mimicry between Streptococcus pyogenes M protein and host tissues triggers autoimmune cross-reactivity.
Type II hypersensitivity reaction leads to inflammation of heart, joints, skin, and CNS tissues.
Aschoff bodies form as granulomatous lesions in the myocardium causing pancarditis.
T-cell mediated immune response contributes to tissue damage in affected organs.
Antibody-mediated damage to cardiac myocytes and valves results in chronic valvulitis.
| Involvement | Details |
|---|---|
| Organs | Heart is the primary organ affected, with inflammation of the endocardium, myocardium, and pericardium causing carditis and valvular damage. |
Joints commonly present with migratory arthritis involving large joints such as knees and ankles. | |
Central nervous system involvement can cause Sydenham chorea characterized by involuntary movements. | |
| Tissues | Cardiac connective tissue is targeted by autoimmune inflammation leading to valvulitis and myocarditis. |
Synovial tissue becomes inflamed causing migratory polyarthritis typical of rheumatic fever. | |
Subcutaneous tissue may develop painless nodules due to localized granulomatous inflammation. | |
| Cells | CD4+ T cells mediate the autoimmune response by recognizing cross-reactive streptococcal antigens and attacking host tissues. |
Macrophages participate in granulomatous inflammation forming Aschoff bodies characteristic of rheumatic fever. | |
B cells produce antibodies against Streptococcus pyogenes that cross-react with cardiac tissue causing molecular mimicry. | |
| Chemical Mediators | Tumor necrosis factor-alpha (TNF-α) promotes inflammation and tissue damage in affected heart valves and joints. |
Interleukin-1 (IL-1) contributes to fever and systemic inflammatory response in rheumatic fever. | |
Anti-streptolysin O (ASO) antibodies serve as serologic markers indicating recent Streptococcus pyogenes infection. |
Treatments
Pharmacological Treatments
Penicillin
- Mechanism:
Bactericidal antibiotic that inhibits bacterial cell wall synthesis targeting Streptococcus pyogenes.
- Side effects:
Allergic reactions
Anaphylaxis
Gastrointestinal upset
- Clinical role:
First-line
Aspirin
- Mechanism:
Nonsteroidal anti-inflammatory drug that inhibits cyclooxygenase enzymes reducing inflammation and fever.
- Side effects:
Gastrointestinal bleeding
Tinnitus
Allergic reactions
- Clinical role:
Adjunctive
Corticosteroids
- Mechanism:
Potent anti-inflammatory agents that suppress immune-mediated tissue damage in severe carditis.
- Side effects:
Immunosuppression
Hyperglycemia
Osteoporosis
- Clinical role:
Adjunctive
Non-pharmacological Treatments
Bed rest during the acute phase to reduce cardiac workload and prevent complications.
Long-term prophylaxis with intramuscular benzathine penicillin to prevent recurrent Streptococcus pyogenes infections and rheumatic fever relapse.
Prevention
Pharmacological Prevention
Penicillin prophylaxis to eradicate Group A Streptococcus and prevent recurrence
Long-term benzathine penicillin G injections every 3-4 weeks for secondary prevention
Anti-inflammatory treatment with aspirin or corticosteroids to reduce carditis severity
Antibiotic treatment of acute streptococcal pharyngitis to prevent initial rheumatic fever
Symptomatic management of chorea with neuroleptics or anticonvulsants if severe
Non-pharmacological Prevention
Prompt diagnosis and treatment of streptococcal pharyngitis to prevent immune sequelae
Regular cardiac monitoring in patients with history of rheumatic fever
Education on adherence to secondary prophylaxis to reduce recurrence risk
Avoidance of strenuous physical activity during acute carditis to prevent heart failure
Screening family members for streptococcal infections in endemic areas
Outcome & Complications
Complications
Chronic rheumatic heart disease with progressive valvular stenosis or regurgitation
Heart failure due to severe valvulitis and myocardial involvement
Arrhythmias secondary to carditis and conduction system inflammation
Infective endocarditis on damaged valves
Permanent neurological deficits from severe or prolonged Sydenham chorea
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Rheumatic Fever (Streptococcus pyogenes - Group A Streptococcus) versus Infective Endocarditis
Rheumatic Fever (Streptococcus pyogenes - Group A Streptococcus) | Infective Endocarditis |
|---|---|
Recent untreated pharyngitis with Group A Streptococcus | History of intravenous drug use or recent invasive procedures |
Elevated antistreptolysin O (ASO) titers without positive blood cultures | Positive blood cultures with causative bacteria |
Post-infectious autoimmune reaction occurring weeks after initial infection | Subacute or acute persistent infection with continuous fever |
Echocardiogram showing valvulitis or mitral valve regurgitation without vegetations | Echocardiogram showing vegetations on heart valves |
Rheumatic Fever (Streptococcus pyogenes - Group A Streptococcus) versus Juvenile Idiopathic Arthritis (JIA)
Rheumatic Fever (Streptococcus pyogenes - Group A Streptococcus) | Juvenile Idiopathic Arthritis (JIA) |
|---|---|
Acute arthritis following recent Group A Streptococcus pharyngitis in school-age children | Chronic arthritis onset typically before age 16 without preceding infection |
Migratory arthritis resolving within days to weeks | Chronic joint inflammation lasting >6 weeks |
Post-infectious autoimmune response with elevated ASO titers and evidence of molecular mimicry | Autoimmune arthritis with variable ANA positivity |
Elevated ESR, CRP, and ASO titers indicating recent streptococcal infection | Normal or mildly elevated inflammatory markers without evidence of recent streptococcal infection |
Rheumatic Fever (Streptococcus pyogenes - Group A Streptococcus) versus Systemic Lupus Erythematosus (SLE)
Rheumatic Fever (Streptococcus pyogenes - Group A Streptococcus) | Systemic Lupus Erythematosus (SLE) |
|---|---|
Absence of ANA; presence of elevated ASO titers | Presence of antinuclear antibodies (ANA) and anti-dsDNA antibodies |
Acute post-infectious syndrome with self-limited course | Chronic relapsing-remitting course with multisystem involvement |
Normal complement levels with elevated inflammatory markers and ASO titers | Hypocomplementemia with positive lupus serologies |
Preceding Group A Streptococcus pharyngitis | No preceding bacterial infection |
Rheumatic Fever (Streptococcus pyogenes - Group A Streptococcus) versus Kawasaki Disease
Rheumatic Fever (Streptococcus pyogenes - Group A Streptococcus) | Kawasaki Disease |
|---|---|
Typically affects children aged 5-15 years | Primarily affects children under 5 years old |
Elevated ASO titers with normal or mildly elevated platelets | Elevated platelet count and sterile pyuria without elevated ASO titers |
Fever with migratory polyarthritis and carditis following streptococcal infection | Fever lasting at least 5 days with mucocutaneous inflammation |
Elevated ASO titers and evidence of recent Group A Streptococcus infection | No specific serologic test; diagnosis clinical |
Rheumatic Fever (Streptococcus pyogenes - Group A Streptococcus) versus Post-Streptococcal Glomerulonephritis
Rheumatic Fever (Streptococcus pyogenes - Group A Streptococcus) | Post-Streptococcal Glomerulonephritis |
|---|---|
Follows Group A Streptococcus pharyngitis with systemic autoimmune features | Follows Group A Streptococcus skin infection or pharyngitis |
Elevated ASO titers with normal complement and migratory arthritis | Hematuria, red blood cell casts, and low complement levels |
Onset of arthritis, carditis, and chorea 2-4 weeks after infection | Acute nephritic syndrome developing 1-3 weeks after infection |
No renal biopsy findings; diagnosis based on Jones criteria | Renal biopsy showing immune complex deposition |